257 related articles for article (PubMed ID: 27472713)
1. Elevated expression of growth-regulated oncogene-alpha in tumor and stromal cells predicts unfavorable prognosis in pancreatic cancer.
Lian S; Zhai X; Wang X; Zhu H; Zhang S; Wang W; Wang Z; Huang J
Medicine (Baltimore); 2016 Jul; 95(30):e4328. PubMed ID: 27472713
[TBL] [Abstract][Full Text] [Related]
2. High expression of PFTK1 in cancer cells predicts poor prognosis in colorectal cancer.
Mao Y; Jia Y; Zhu H; Wang W; Jin Q; Huang F; Zhang S; Li X
Mol Med Rep; 2017 Jul; 16(1):224-230. PubMed ID: 28498444
[TBL] [Abstract][Full Text] [Related]
3. [Expression and clinical significance of Tspan 1 and Integrin α6 in human pancreatic ductal adenocarcinoma].
Shi G; Dong M; Sheng W; Zhou J; Yu D; Sun W
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):781-6. PubMed ID: 25573220
[TBL] [Abstract][Full Text] [Related]
4. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
[TBL] [Abstract][Full Text] [Related]
5. Over-Expression of Alpha-Enolase as a Prognostic Biomarker in Patients with Pancreatic Cancer.
Sun L; Guo C; Cao J; Burnett J; Yang Z; Ran Y; Sun D
Int J Med Sci; 2017; 14(7):655-661. PubMed ID: 28824297
[No Abstract] [Full Text] [Related]
6. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma.
Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H
Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028
[TBL] [Abstract][Full Text] [Related]
7. Role of lumican in cancer cells and adjacent stromal tissues in human pancreatic cancer.
Ishiwata T; Cho K; Kawahara K; Yamamoto T; Fujiwara Y; Uchida E; Tajiri T; Naito Z
Oncol Rep; 2007 Sep; 18(3):537-43. PubMed ID: 17671699
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
9. Human antigen R mediated post-transcriptional regulation of inhibitors of apoptosis proteins in pancreatic cancer.
Lukosiute-Urboniene A; Jasukaitiene A; Silkuniene G; Barauskas V; Gulbinas A; Dambrauskas Z
World J Gastroenterol; 2019 Jan; 25(2):205-219. PubMed ID: 30670910
[TBL] [Abstract][Full Text] [Related]
10. Decreased TIP30 expression predicts poor prognosis in pancreatic cancer patients.
Guo S; Jing W; Hu X; Zhou X; Liu L; Zhu M; Yin F; Chen R; Zhao J; Guo Y
Int J Cancer; 2014 Mar; 134(6):1369-78. PubMed ID: 24037692
[TBL] [Abstract][Full Text] [Related]
11. High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma.
Huang J; Fan X; Wang X; Lu Y; Zhu H; Wang W; Zhang S; Wang Z
Sci Rep; 2015 Aug; 5():12991. PubMed ID: 26259918
[TBL] [Abstract][Full Text] [Related]
12. High Expression of Cell Division Cycle 42 Promotes Pancreatic Cancer Growth and Predicts Poor Outcome of Pancreatic Cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract][Full Text] [Related]
13. The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis.
Yang G; Rosen DG; Zhang Z; Bast RC; Mills GB; Colacino JA; Mercado-Uribe I; Liu J
Proc Natl Acad Sci U S A; 2006 Oct; 103(44):16472-7. PubMed ID: 17060621
[TBL] [Abstract][Full Text] [Related]
14. Expression of UGP2 and CFL1 expression levels in benign and malignant pancreatic lesions and their clinicopathological significance.
Wang L; Xiong L; Wu Z; Miao X; Liu Z; Li D; Zou Q; Yang Z
World J Surg Oncol; 2018 Jan; 16(1):11. PubMed ID: 29347944
[TBL] [Abstract][Full Text] [Related]
15. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma.
Hiroshima Y; Kasajima R; Kimura Y; Komura D; Ishikawa S; Ichikawa Y; Bouvet M; Yamamoto N; Oshima T; Morinaga S; Singh SR; Hoffman RM; Endo I; Miyagi Y
Cancer Lett; 2020 Jan; 469():217-227. PubMed ID: 31669204
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomas.
Zhou J; Song SD; Li DC; Zhou J; Zhu DM; Zheng SY
Asian Pac J Cancer Prev; 2012; 13(2):719-24. PubMed ID: 22524850
[TBL] [Abstract][Full Text] [Related]
17. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
18. Elevated CXCL1 expression in breast cancer stroma predicts poor prognosis and is inversely associated with expression of TGF-β signaling proteins.
Zou A; Lambert D; Yeh H; Yasukawa K; Behbod F; Fan F; Cheng N
BMC Cancer; 2014 Oct; 14():781. PubMed ID: 25344051
[TBL] [Abstract][Full Text] [Related]
19. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients.
Yu LM; Zhu YS; Xu CZ; Zhou LL; Xue ZX; Cai ZZ
Clin Transl Oncol; 2019 Jul; 21(7):924-932. PubMed ID: 30565085
[TBL] [Abstract][Full Text] [Related]
20. Elevated Transient Receptor Potential Melastatin 8 (TRPM8) Expression Is Correlated with Poor Prognosis in Pancreatic Cancer.
Du JD; Zheng X; Chen YL; Huang ZQ; Cai SW; Jiao HB; Zhu ZM; Hu B
Med Sci Monit; 2018 Jun; 24():3720-3725. PubMed ID: 29860264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]